FDA wants further testing of Lilly pancreas drug



















Indianapolis-based Lilly acquired the drug as part of its $180 million acquisition of Alnara last summer.


Another $180 million down the drain. That equates to the salaries for at least 1,800 people.

Whose bright idea was it to buy Alnara for another worthless product?
 






As an FDE... it couldn't have happened to a more quality employer. I don't care the least bit about any Lily set-backs. I simply don't care.

Most FTE's don't care either. It's just a lot of lies from the M-level down to the ranks. Even within and between different M-levels.

As always, the lawyers think they are the only ones who know what's going on... and they are probably playing both sides, too.